Table 3

Association between IMDC outcome and fecal calprotectin concentration at IMDC onset and after treatment of IMDC (N=77)

IMDC outcomen (%)FC concentration at IMDC onsetFC concentration after IMDC treatment
Mean±SD, μg/gP valueMean±SD, μg/gP value
Clinical remission0.0190.064
 Yes65 (84)406±38136±9
 No12 (16)641±98180±15
Endoscopic remission0.006<0.001
 Yes46 (60)361±44110±8
 No31 (40)563±59184±13
Histologic remission0.0970.029
 Yes24 (31)352±60114±11
 No53 (69)483±41152±10
Recurrent IMDC0.0800.804
 Yes16 (21)317±62136±17
 No61 (79)475±43141±9
  • FC, fecal calprotectin; IMDC, immune-mediated diarrhea and colitis.